ID   RMS13
AC   CVCL_S112
DR   Wikidata; Q54950706
RX   PubMed=9823299;
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
RX   PubMed=9823299;
RA   Khan J., Simon R.M., Bittner M., Chen Y.-D., Leighton S.B., Pohida T.,
RA   Smith P.D., Jiang Y., Gooden G.C., Trent J.M., Meltzer P.S.;
RT   "Gene expression profiling of alveolar rhabdomyosarcoma with cDNA
RT   microarrays.";
RL   Cancer Res. 58:5009-5013(1998).
//
RX   PubMed=14704789; DOI=10.1038/nm966;
RA   Yu Y.-L., Khan J., Khanna C., Helman L.J., Meltzer P.S., Merlino G.T.;
RT   "Expression profiling identifies the cytoskeletal organizer ezrin and
RT   the developmental homeoprotein Six-1 as key metastatic regulators.";
RL   Nat. Med. 10:175-181(2004).
//